List of Iluvien drug patents

Iluvien is owned by Alimera Sciences Inc.

Iluvien contains Fluocinolone Acetonide.

Iluvien has a total of 1 drug patent out of which 0 drug patents have expired.

Iluvien was authorised for market use on 26 September, 2014.

Iluvien is available in implant;intravitreal dosage forms.

The generics of Iluvien are possible to be released after 12 August, 2027.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8871241 ALIMERA SCIENCES INC Injectable sustained release delivery devices
Aug, 2027

(4 years from now)

Drugs and Companies using FLUOCINOLONE ACETONIDE ingredient

Market Authorisation Date: 26 September, 2014

Treatment: NA

Dosage: IMPLANT;INTRAVITREAL

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in